Deep Capture » Intermune http://www.deepcapture.com Investigating naked short selling, economic warfare, and the financial crisis Mon, 06 Feb 2012 23:20:58 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 2010 ekarpak@deepcapture.com (Judd Bagley) ekarpak@deepcapture.com (Judd Bagley) Business 1440 http://www.deepcapture.com/wp-content/uploads/144-logo.jpg Deep Capture http://www.deepcapture.com 144 144 Independent investigations into illegal naked short selling. A massive financial crime is occurring within the United States. The institutions that should be stopping it have been captured by the criminals who are doing it. Corporate governance has turned into a hoax while companies are destroyed, pensions looted, society is deprived of innovations, and the nation's financial system may implode. The financial press is so willfully blind it borders on a cover-up. The dots are being connected in the world of social media, but the same criminals who are behind the financial scam are manipulating social media to forestall the day of social epiphany. And yes, I know this all sounds like a bad Sandra Bullock movie. By Patrick Byrne economy, hedge fund, fraud, manipulation, deep capture, stock market, investing, Wall Street Judd Bagley Judd Bagley ekarpak@deepcapture.com no no Hedge Funds to Non-Cancer Patients: “You also die.” http://www.deepcapture.com/hedge-funds-to-folks-with-other-medical-issues-you-should-die-too/ http://www.deepcapture.com/hedge-funds-to-folks-with-other-medical-issues-you-should-die-too/#comments Fri, 05 Dec 2008 18:48:41 +0000 Patrick Byrne http://www.deepcapture.com/?p=489 Stock manipulators think not just cancer patients can die to pay for ski trips to Gstaad. They also think those suffering from various pulmonary and blood diseases can die, too.

InterMune, Inc., is a California firm that focuses on the research, development, and commercialization of therapies in pulmonology and hepatology. It generates over $50 million/year in revenue, primarily from Actimmune, for patients with osteopetrosis and chronic granulomatous disease. It’s candidate drug Pirfenidone is in phase III clinical trials for the treatment of idiopathic pulmonary fibrosis. Its candidate drug ITMN-191, a hepatitis C virus protease inhibitor, is is in Phase Ib clinical trials to treat patients with HCV infections. It has license and collaboration agreements with some of the most prestigious names in biotech: Hoffmann-LaRoche, Inc. and F. Hoffmann-LaRoche, Ltd.; Genentech, Inc.; Connetics Corporation; Boehringer Ingelheim International GmbH; Novartis Corporation; Array BioPharma, Inc.; Eli Lilly & Company; and ALZA Corporation.

Stock manipulators think people with such medical problems can die, as they express by manipulating the price of InterMune stock so that InterMune cannot fund its research by accessing the capital market at the true market-clearing price of its stock.

intermune itmn naked short selling Hedge Funds to Non Cancer Patients: You also die.


==========================================================

In the interests of journalistic integrity, I should disclose that I don’t much like the people doing this.

If this article concerns you, and you wish to help, then:

1) email it to a dozen friends;

2) go here for additional suggestions: “So You Say You Want a Revolution?“

]]> http://www.deepcapture.com/hedge-funds-to-folks-with-other-medical-issues-you-should-die-too/feed/ 19